Results 211 to 220 of about 1,279,892 (312)

Nail Disorders in Systemic Conditions

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley   +1 more source

Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres   +4 more
wiley   +1 more source

Osimertinib, a Trigger of Subacute Cutaneous Lupus Erythematosus: Three-Patient Case Series and Literature Review. [PDF]

open access: yesClin Cosmet Investig Dermatol
Nowiszewska J   +6 more
europepmc   +1 more source

Paediatric Melanonychia: Diagnosis and Management

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Longitudinal melanonychia (LM) in children presents unique diagnostic and management challenges that cannot be adequately addressed by applying adult‐based criteria. Unlike in adults, there are no validated clinical, dermoscopic or histopathologic criteria for predicting nail unit melanoma in the paediatric population.
Angela J. Jiang   +5 more
wiley   +1 more source

Individual and Societal Economic Burden of Atopic Dermatitis: A Nationwide Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
Using nationwide registry‐based data, this study estimates the economic burden of atopic dermatitis. Each individual with atopic dermatitis incurs an annual excess cost of €2172, driven mainly by foregone income rather than direct healthcare expenditure. ABSTRACT Background Atopic dermatitis (AD) imposes a significant economic burden for individuals as
Martino Renzi‐Lomholt   +7 more
wiley   +1 more source

Pembrolizumab‐Induced Subacute Cutaneous Lupus Erythematosus: A Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Subacute cutaneous lupus erythematosus (SCLE) is an increasingly recognized cutaneous immune‐related adverse event of immune checkpoint inhibitors. We report an 83‐year‐old woman who developed pruritic annular and polycyclic plaques 10 weeks after starting pembrolizumab for oropharyngeal squamous cell carcinoma.
Sebastiano Posenato   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy